Healthcare presents unparalleled opportunities for growth-stage investments. Here’s why: 1. Sector-Specific Expertise: Healthcare-focused funds provide the deep technical knowledge required to navigate this complex landscape effectively. 2. Strong Exit Potential: Healthcare buyouts surged last year, making it the second-largest sector for deals, with sovereign funds and family offices driving exits. 3. Innovation at Scale: Growth-stage healthcare companies are primed to scale rapidly, often reaching IPO maturity within 5–6 years. Our Healthcare Opportunities Fund is building a balanced portfolio across high-growth sub-sectors, including: 1. Diagnostics and medical devices. 2. Healthtech companies driving digital transformation. 3. Single-specialty services delivering targeted expertise and superior outcomes. What’s our approach? We focus on minority investments, empowering visionary entrepreneurs while providing capital and strategic support. With a mix of B2B and B2C plays, we’re also open to collaborations with buyout funds for platform-based opportunities. Read more from Tarun Sharma, Fund Manager, Healthcare and Consumer at 360 ONE Asset, in his exclusive interview with VCCircle: https://lnkd.in/dhtP--wz #360ONE #HealthcareInvestments #GrowthStage 360 ONE
360 ONE Asset’s Post
More Relevant Posts
-
Nelson Advisors Partner and HealthTech M&A Advisor Lloyd Price sharing his thoughts on the Healthcare Technology IPO market - candidates, timings and sub sectors to watch, with the team at MergerMarket https://lnkd.in/eqDypnd2 'Lloyd Price, a partner at Nelson Advisors who specializes in healthcare, referred to a “corrective IPO market” and said listing candidates in the health tech and digital health sectors should boast, at least, USD 100M EBITDA. This is an increase on the previously acceptable USD 60m to USD 70m EBITDA to list on either Nasdaq or NYSE, he said. He concurred that strong candidates for IPOs in healthcare technology need long-term provider contracts which cannot be easily replaced, making both predictable revenue streams as well as being able to address value-based care models. Price mentioned, among possible IPO candidates, Kaia Health, Sword Health and Hinge Health, all of which operate in a massive addressable market and have developed new care delivery platforms with AI to predict better outcomes. They also benefit from the tailwinds of the musculoskeletal market post-pandemic and a shift to working-from-home. Other potential candidates Price mentioned include Aledade, a primary care platform for clinical decision support, and Omada Health, which is tapping into the chronic disease management market with both online and offline support channels. Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/eeX9Bcwa #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy https://lnkd.in/eqDypnd2
To view or add a comment, sign in
-
Nelson Advisors Partner and HealthTech M&A Advisor Lloyd Price sharing his thoughts on the Healthcare Technology IPO market - candidates, timings and sub sectors to watch, with the team at MergerMarket https://lnkd.in/eieA_uwf 'Lloyd Price, a partner at Nelson Advisors who specializes in healthcare, referred to a “corrective IPO market” and said listing candidates in the health tech and digital health sectors should boast, at least, USD 100M EBITDA. This is an increase on the previously acceptable USD 60m to USD 70m EBITDA to list on either Nasdaq or NYSE, he said. He concurred that strong candidates for IPOs in healthcare technology need long-term provider contracts which cannot be easily replaced, making both predictable revenue streams as well as being able to address value-based care models. Price mentioned, among possible IPO candidates, Kaia Health, Sword Health and Hinge Health, all of which operate in a massive addressable market and have developed new care delivery platforms with AI to predict better outcomes. They also benefit from the tailwinds of the musculoskeletal market post-pandemic and a shift to working-from-home. Other potential candidates Price mentioned include Aledade, a primary care platform for clinical decision support, and Omada Health, which is tapping into the chronic disease management market with both online and offline support channels. Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/e25VecXk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy https://lnkd.in/eieA_uwf
Strong vitals: HealthTech IPO candidates expect tailwinds
healthcare.digital
To view or add a comment, sign in
-
Multi-strategy funds and private equity firms are pivotal in driving innovation and scalability, especially in #Healthcare. These investors are strategically navigating the complexities of the sector, capitalizing on its potential for growth and transformation. #MultiStrategy #MedTech
Multi-Strategy Funds and Private Equity: Catalysts for Scalable Innovations in Healthcare Technology | Legacy Capital, LLC.
legacycap.pro
To view or add a comment, sign in
-
Value creation in healthcare - The four key pillars we at LeapFrog Investments healthcare team focus on for profit + purpose driven results: 🏢 Corporate governance 💉 Clinical quality 🤝 Customer centricity 📈 Profitable growth I enjoyed speaking about this and other aspects of our #healthcare investment thesis with Vibhuti Sharma of DealStreetAsia https://lnkd.in/gRVxA7Xu #healthcare #privateequity #impactinvesting
Indian healthtech firms now fairly valued amid market shift, says Leapfrog exec
dealstreetasia.com
To view or add a comment, sign in
-
🚀 Exciting times in the Healthcare IT space! 🌟 Just reviewed some fascinating insights from the latest market trends, and here are my key takeaways: 📊 Funding is booming! 1. $1B raised in VC funding across 74 deals this quarter! 💰 2. Top Deal: A whopping $150M Series C for Abridge, led by Lightspeed and Redpoint Ventures. 📝✨ 🔍 Emerging Opportunities: 1. Diabetes Care Management: Significant advancements are underway. 2. Remote Monitoring for Chronic Conditions: The landscape is evolving rapidly, with incredible potential. As we continue to innovate in healthcare, staying ahead of these trends is crucial. Let's leverage these emerging opportunities to drive impactful change and improve patient outcomes. 🌐💡 Together, we can push the boundaries of what's possible in healthcare tech! 💪🏼🚀 #HealthcareIT #VentureCapital #Innovation #TechTrends #Healthcare
To view or add a comment, sign in
-
Private equity and venture capital investments in the healthcare services sector experienced a significant 59% year-over-year decline in 2023, totaling $7.26 billion, marking its lowest annual value in three years, as per S&P Global Market Intelligence data. The number of deals also saw a notable decrease, dropping approximately 33% from 462 to 310 compared to the previous year. Interestingly, the deal count for 2023 stands as the lowest since at least 2019. On a positive note, there has been an increase in health tech investing amidst these shifts.
Private equity investment in healthcare services falls 59% in 2023
spglobal.com
To view or add a comment, sign in
-
10 Key Variables in HealthTech M&A valuation multiples https://lnkd.in/eqqcSTQ5 The combination of technological advancements, regulatory changes, market dynamics, and increased investor interest is driving healthtech M&A valuations to new heights. Companies with innovative technologies, strong market positions, and the potential to address significant healthcare challenges are likely to be highly valued in today's M&A market. In terms of valuation, the 10 Key Variables in HealthTech M&A valuation multiples today are: 1) Stage of the company's development: Early-stage companies are typically valued at a lower multiple than more mature companies. 2) Size of the company: Larger companies are typically valued at a higher multiple than smaller companies. 3) Intellectual property portfolio: Companies with valuable intellectual property are typically valued at a higher multiple. 4) Quality of the management team: A strong management team can add value to a company and may lead to a higher valuation. 5) Revenue growth: This is one of the most important factors in determining the valuation of a healthtech company. Companies with strong revenue growth are typically valued at a premium to those with slower growth. 6) Gross margin: Gross margin is a measure of a company's profitability. Companies with higher gross margins are typically valued at a premium to those with lower margins. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy
10 Key Variables in HealthTech M&A valuation multiples
healthcare.digital
To view or add a comment, sign in
-
20+ Digital Health companies went public in 2021: Where are they now? https://lnkd.in/eNCUk_DY There were a confluence of factors that fueled the surge of digital health companies going public in 2021: 1. Pandemic-driven Growth: The COVID-19 pandemic accelerated the adoption of digital health solutions. Telemedicine, remote monitoring, and other digital tools became crucial for patients and healthcare providers. This growth in usage attracted investor interest in the potential of the digital health market. 2. Increased Investor Appetite: Investors, buoyed by the overall market optimism in 2021, were looking for promising new sectors. The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. 3. Rise of SPACs: Special Purpose Acquisition Companies (SPACs) became a popular alternative to traditional IPOs in 2021. SPACs offered a faster and potentially less regulated path to going public, which appealed to many digital health companies. 4. Competitive Landscape: With more investor dollars flowing into the space, companies felt pressure to go public before their competitors to secure funding and establish themselves in the market. In essence, it was a perfect storm of factors: a growing market, eager investors, a new and faster funding option, and a competitive environment. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk https://lnkd.in/eNCUk_DY
20+ Digital Health companies went public in 2021: Where are they now?
healthcare.digital
To view or add a comment, sign in
-
🎉 We are excited to unveil GrowthCap's annual list of top healthcare investors Investors who are shaping the industry through strategic insights and innovative investments. Check out some of them below: ✅ Jeffrey Crisan, Silversmith Capital Partners - Co-founder focusing on transformative healthcare IT & services, driving significant growth and operational excellence. ✅ John Maldonado, Advent International - Spearheads impactful healthcare transactions and innovations with a strong focus on healthcare and tech. ✅ Jeff Haywood, Spectrum Equity - Co-head of healthcare investments, enhancing care access and efficiency across the healthcare spectrum. ✅ Steve LeSieur, Spectrum Equity - Co-leads with Jeff, focusing on scalable healthcare solutions that drive substantial value. ✅ David Schuppan, The Vistria Group - Senior Partner known for his expertise in in-home and value-based care, with a track record of successful exits. ✅ Andrew Adams, Oak HC/FT - Co-Founder & Managing Partner focusing on healthcare and fintech, with a history of successful investments including several IPOs. ✅ Garheng Kong , HealthQuest Capital - Managing Partner & Founder with a strong focus on improving healthcare delivery and outcomes through strategic investments. ✅ Dr. Robert Mittendorff, MD, MBA, B Capital - General Partner and Head of Healthcate, investing in transformative biotech, medtech, and healthtech companies. ✅ Katherine Wood, TPG - Partner in charge of advancing healthcare innovation and driving value across systems, emphasizing tailored and effective care solutions. 🔗 Visit the full list here: https://lnkd.in/gaVUV4Qa #HealthcareInvestment #Investors #Healthcare #Healthcare
To view or add a comment, sign in
-
20+ Digital Health companies went public in 2021: Where are they now? https://lnkd.in/eNCUk_DY There were a confluence of factors that fueled the surge of digital health companies going public in 2021: > Pandemic-driven Growth: The COVID-19 pandemic accelerated the adoption of digital health solutions. Telemedicine, remote monitoring, and other digital tools became crucial for patients and healthcare providers. This growth in usage attracted investor interest in the potential of the digital health market. > Increased Investor Appetite: Investors, buoyed by the overall market optimism in 2021, were looking for promising new sectors. The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. > Rise of SPACs: Special Purpose Acquisition Companies (SPACs) became a popular alternative to traditional IPOs in 2021. SPACs offered a faster and potentially less regulated path to going public, which appealed to many digital health companies. > Competitive Landscape: With more investor dollars flowing into the space, companies felt pressure to go public before their competitors to secure funding and establish themselves in the market. In essence, it was a perfect storm of factors: a growing market, eager investors, a new and faster funding option, and a competitive environment. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk https://lnkd.in/eNCUk_DY
20+ Digital Health companies went public in 2021: Where are they now?
healthcare.digital
To view or add a comment, sign in
7,053 followers